EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Improvement of Health‐Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary Aldosteronism

Sybille Fuld iD, Christian Adolf, Georgiana Constantinescu, Manuel Schulze, Denise Brüdgam, Carmina T Fuss, Hanna Remde, Lydia Kürzinger, Sven Gruber iD, Jun Yang iD, Amy Kang, Martin Reincke und 4 weitere

Clinical Endocrinology · 2026

DOI: 10.1111/cen.70106 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Sybille Fuld und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität, Dresden, Germany. Hauptthemen laut MEDLINE: Quality of Life, Hyperaldosteronism, Adrenalectomy, Mental Health. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, the Clinical Research Priority Program of the University of Zurich, the Else Kröner-Fresenius Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary aldosteronism (PA) has been linked with reduced health‐related quality of life (QoL) and increased prevalence of anxiety and depression. While most studies compared patients with PA to healthy subjects, this study focused on comparison with hypertensive patients without PA to identify PA‐specific effects. Furthermore, the impact of targeted therapy on QoL and mental health was evaluated.

Methods

Mental and physical health‐related QoL, anxiety and presence of depressive and panic symptoms were assessed using the SF‐12, GAD‐7 and PHQ questionnaires in 925 patients with arterial hypertension tested for PA in a prospective, multi‐center international prospective cohort study. Questionnaires were assessed at baseline as well as 3−6 months after initiation of targeted therapy.

Results

Amongst 833 of 925 patients who completed the necessary diagnostic procedures, 211 were diagnosed with PA. 98 of 116 patients with unilateral PA received unilateral adrenalectomy. At baseline, QoL, anxiety and mental health scores did not differ in patients with PA vs patients with hypertension without PA. At outcome assessment, SF‐12 mental and physical component summaries as well as GAD‐7 specifically improved in patients with unilateral PA after adrenalectomy (mean Δ = 4.2, p = 0.018, Δ = 3.6, p = 0.038 and Δ = −1.9, p = 0.006, respectively) in contrast to no improvement in patients with PA on MRA treatment.

Conclusions

There was no difference in health‐related QoL, anxiety and mental health in patients with hypertension with versus without PA. Unilateral adrenalectomy but not medical therapy improved health‐related QoL and decreased anxiety in patients with PA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeHyperaldosteronismAdrenalectomyMental HealthHumansFemaleMaleMiddle AgedProspective StudiesAdultHypertensionAnxietySurveys and QuestionnairesDepressionAged

Stichwörter der Autor:innen

adrenalectomyaldosteronehypertensionmental healthmineralocorticoid receptor antagonistsmineralocorticoidsquality of life

Autor:innen und Institutionen

  • Department of Medicine III, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität, Dresden, Germany.
  • Department of Medicine IV, University Hospital, Ludwig Maximilians University, Munich, Germany.
  • Center for Interdisciplinary Digital Sciences (CIDS), Center for Information Services and High Performance Computing, Technische Universität, Dresden, Germany.
  • Department of Internal Medicine I, Division of Endocrinology and Diabetes, BG Universitätsklinikum Bochum, Ruhr-Universität, Bochum, Germany.
  • Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Germany.
  • Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.

ORCID-Profile: Sybille Fuld, Sven Gruber, Jun Yang, Graeme Eisenhofer

Förderung

  • Deutsche Forschungsgemeinschaft
  • the Clinical Research Priority Program of the University of Zurich
  • the Else Kröner-Fresenius Stiftung
  • the Eva Luise and Horst Köhler Stiftung
  • the Australian Medical Research Future Fund
  • the Australian National Health and Medical Research Council

Zitieren

APA

Fuld, S., Adolf, C., Constantinescu, G., Schulze, M., Brüdgam, D., Fuss, C. T., Remde, H., Kürzinger, L., Gruber, S., Yang, J., Kang, A., Reincke, M., Beuschlein, F., Eisenhofer, G., Lenders, J. W. M., & Pamporaki, C. (2026). Improvement of Health‐Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary Aldosteronism. Clinical Endocrinology. https://doi.org/10.1111/cen.70106

Vancouver

Fuld S, Adolf C, Constantinescu G, Schulze M, Brüdgam D, Fuss CT, et al. Improvement of Health‐Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary Aldosteronism. Clinical Endocrinology. 2026. doi:10.1111/cen.70106

BibTeX
@article{Fuld2026,
  author = {Fuld, Sybille and Adolf, Christian and Constantinescu, Georgiana and Schulze, Manuel and Brüdgam, Denise and Fuss, Carmina T and Remde, Hanna and Kürzinger, Lydia and Gruber, Sven and Yang, Jun and Kang, Amy and Reincke, Martin and Beuschlein, Felix and Eisenhofer, Graeme and Lenders, Jacques W M and Pamporaki, Christina},
  title = {Improvement of Health‐Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary Aldosteronism},
  journal = {Clinical Endocrinology},
  year = {2026},
  doi = {10.1111/cen.70106}
}
Kostenlos starten →